You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
君實生物(01877.HK)以藥物資產向合資公司注資約3,060萬元人幣
君實生物(01877.HK)公布,以出資資產方式向合資公司注資3,059.78萬元人民幣(下同),當中14萬元屬合資公司註冊資本,佔合資公司的經擴大股權約9.45%。 公司指,出資的藥物尚處於早期研發階段,為盡快推進相關藥物的商業化,公司必須開展臨床試驗並投入充足的資金,通過增資事項,以合資公司作為融資平台引入外部資金,為相關藥物的研發提供資金支持。 如合資公司未能在18個月內取得不少於3,000萬美元的估值、或取得新投資人不少於1,500萬美元的融資,公司有權單方面終止合資協議。 合資公司非執行董事馮輝等持有,因此屬關連交易,將於臨時股東大會審議。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account